TNF and periodontal disorder: It has been described that the release of interleukin (IL) 1 beta (IL-1B) and tumor necrosis factor alpha (TNF-A), inhibit leukocyte trafficking and attenuate the inflammatory reactions caused by Porphyromonas gingivalis, gives strength to the potential protective role in periodontal disease [6].